Latest Breaking News On - ஆண்ட்ரூ சைக் - Page 1 : comparemela.com
Intercept Pharmaceuticals, inc (ICPT) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Intercept Appoints Andrew Saik as Chief Financial Officer
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Operator
Good morning, and welcome to the VYNE Therapeutics conference call to discuss the first-quarter 2021 financial results and update. [Operator instructions] Please be advised that this call is being recorded at the company s request. I will now turn the call over to Michael Wood at LifeSci Advisors. Please go ahead.
Michael Wood
LifeSci Advisors Managing Director
Good morning, everyone, and thank you for joining us. Before we begin formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict including statements, forecasts and observations regarding future financial operating performance, impacts of the COVID-19 pandemic online and observations regarding ongoing operating expenses and net revenue. These statements include observations associated with commercialization of AMZEEQ and ZIL
VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble.
VYNE Therapeutics Inc. (NASDAQ: VYNE)
Q4 2020 Earnings Call
Good morning and welcome to the VYNE Therapeutics conference call to discuss the fourth-quarter and full-year 2020 financial results and update. [Operator instructions] Following the company s formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company s request. I will now turn the call over to Michael Wood of LifeSci Advisors.
Please go ahead.
LifeSci Advisors Managing Director
Good morning, everyone, and thanking thank you for joining us this morning. Before we begin with formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties, and assum
VYNE Therapeutics Added to Nasdaq Biotechnology Index
VYNE Therapeutics Added to Nasdaq Biotechnology Index
BRIDGEWATER, N.J., Dec. 16, 2020 VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index (Nasdaq: NBI), based on the results of the annual reconstitution of the index announced by Nasdaq on December 11, 2020. The inclusion will become effective prior to the U.S. market open on Monday, December 21, 2020.
The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market that are classified as either biotechnology or pharmaceutical companies, and is a modified market capitalization weighted index. According to Nasdaq, the NBI is reconstituted annually in December in accordance with a set of eligib
vimarsana © 2020. All Rights Reserved.